Case Study

RPR/Fisons plc

17 pages
April 1997
Reference: IMD-1-0159

After enjoying several decades of fast profit growth the pharmaceutical industry is under threat. Research & Development costs are outstripping the return on investment, many of the best selling drugs are reaching the end of their 20 year patent protection period and there is the increasing threat of regulatory reform. Against this background Fisons plc (Fisons), a medium sized UK pharmaceutical company, is struggling. A new Chief Executive Officer is appointed. The third in three years. In his attempt to revive Fisons he is forced to adopt a radical programme of reform. His harsh medicine appears to be working when Fisons becomes the target of a hostile take-over bid from Rhtne-Poulenc Rorer Inc. (RPR), the giant French pharmaceutical company. Is Fisons able to fight off this bid and remain independent?

Pharmaceuticals, Takeover, Valuation, Financial Analysis, Corporate Strategy
Published Sources
© 1997
Available Languages
Case clearing houses
IMD case studies are distributed through case clearing houses. In order to browse the collection and purchase copies please visit the links below.

The Case Centre

Cranfield University

Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]

Harvard Business School Publishing

60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]

Asia Pacific Case Center

NUCB Business School

1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]


Research Information & Knowledge Hub for additional information on IMD publications

Discover our latest research
IMD's faculty and research teams publish articles, case studies, books and reports on a wide range of topics